首页 | 本学科首页   官方微博 | 高级检索  
检索        

79例紫杉醇注射液致过敏反应文献分析
引用本文:刘朝晖,曾聪彦.79例紫杉醇注射液致过敏反应文献分析[J].中国药物应用与监测,2010,7(2):100-102.
作者姓名:刘朝晖  曾聪彦
作者单位:中山市中医院药剂科,广东,中山,528400
基金项目:中山市科技计划资助项目 
摘    要:目的:探讨紫杉醇注射液致过敏反应的一般规律和特点,促进临床合理用药。方法:检索1994-2009年国内公开发行的医药期刊,对79例紫杉醇注射液致过敏反应病例的年龄与性别分布、过敏反应症状、原患疾病、过敏史、过敏反应出现时间分布、给药剂量、采取急救措施及护理等进行统计分析。结果:紫杉醇注射液致过敏反应多发生于30~60a患者,原患疾病以乳腺癌、肺癌、卵巢癌居多,女性明显多于男性,大多发生在给药10min内。其中,过敏性休克有45例,占56.96%;严重过敏反应有28例,占35.44%。结论:紫杉醇注射液致过敏反应发生率较高,且后果严重,应加以重视。

关 键 词:紫杉醇注射液  过敏反应  文献分析

Analysis of 79 cases of allergic reactions induced by paclitaxel injection
Authors:LIU Zhao-hui  ZENG Cong-yan
Institution:(Department of Pharmacy,Traditional Chinese Medicine Hospital of Zhongshan,Zhongshan 528400,China)
Abstract:Objective:To investigate the general pattern and characteristics of allergic reaction induced by paclitaxel injection and promote rational drug use in clinic.Methods:Seventy nine cases of allergic reactions induced by paclitaxel injection published in Chinese medical journals during 1994-2009 were retrieved and statistically analyzed,including distribution of age and gender,allergy symptom,the primary diseases,allergic history,time distribution of allergic reactions,dosage,first-aid measures and nursing care.Results:Allergic reactions induced by paclitaxel injection occurred more often in patients aged from 30 to 60 years,the major primary diseases of patients were breast carcinoma,pulmonary carcinoma and ovarian cancer,the proportion of female was higher than that of male,and allergic reactions usually occurred within 10 minutes after medication.There were 45 patients(56.96%) suffering from allergic shock and 28 patients(35.44%) developing serious allergic reactions.Conclusion:The occurrence rate of allergic reactions induced by paclitaxel injection is high,and the outcomes are serious,so the rational use of paclitaxel injection in clinic should be paid more attention to.
Keywords:Paclitaxel injection  Allergic reaction  Literature analysis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号